Smith & Nephew SNATS logo
SNNSmith & Nephew SNATS
Trade SNN now
Smith & Nephew SNATS primary media

About Smith & Nephew SNATS

Smith & Nephew SNATS (NYSE:SNN) focuses on developing, manufacturing, and marketing medical devices and solutions across the globe. The company operates in multiple sectors including orthopedics, sports medicine, and wound management, striving to improve patients' lives through their innovative products and therapies. Smith & Nephew SNATS aims to tackle the most pressing challenges in healthcare, such as improving surgical outcomes and enhancing patient recovery times. Their projects often involve cutting-edge technology, like robotics and advanced surgical techniques, to set new standards in medical care. The company's objectives are centered around sustainability, healthcare access expansion, and driving exceptional customer and patient outcomes. Through dedicated research and development, Smith & Nephew SNATS is committed to advancing medical science and transforming the future of healthcare.

What is SNN known for?

Snapshot

Public US
Ownership
1856
Year founded
16692
Employees
London, United Kingdom
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

Produtos e/ou serviços de Smith & Nephew SNATS

  • Advanced Wound Management products, focusing on innovative healing solutions and diagnostics for post-operative wounds.
  • Orthopedics, offering joint replacement systems for knees, hips, and other bones.
  • Sports Medicine portfolio, designed for minimally invasive surgery to treat sports-related injuries.
  • Trauma & Extremities products, providing fixation devices for the repair of fractures and deformity correction procedures.
  • Ear, Nose & Throat (ENT) medical devices dedicated to improving surgical outcomes for ENT conditions.
  • Robotics-assisted surgical systems, enhancing precision in orthopedic surgery for better patient outcomes.

equipe executiva do Smith & Nephew SNATS

  • Dr. Deepak S. Nath Ph.D.CEO & Director
  • Mr. John Terence RogersCFO & Executive Director
  • Mr. Paul ConnollyPresident of Global Operations
  • Mr. Andrew SwiftHead of Investor Relations
  • Ms. Helen BarracloughGroup General Counsel & Company Secretary
  • Ms. Alison ParkesChief Compliance Officer & Compliance APAC
  • Mr. Charles ReynoldsHead of Corporate Communication
  • Dr. Ajay Dhankhar Ph.D.Chief Corporate Development & Strategy Officer
  • Ms. Elga LohlerChief Human Resources Officer
  • Dr. Vasant Padmanabhan Ph.D.President Research & Development, ENT and Emerging Markets

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.